Class Action Alleges Dexatrim Contains Carcinogen

Law360, New York (November 9, 2010, 5:44 PM EST) -- Dexatrim, a weight loss product implicated in product liability litigation over the health risks of phenylpropanolamine, is now facing a class action alleging the pill contains a dangerous carcinogen.

The lawsuit, filed Nov. 4 in the U.S. District Court for the Southern District of Indiana, contends that the product contains hexavalent chromium, a known carcinogen. The suit was filed against Chattem Inc., which makes the product and was recently purchased by Sanofi-Aventis.

The Centers for Disease Control and Prevention says workers exposed to hexavalent chromium compounds...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.